D URING early pregnancy and pseudopregnancy, PRL secreted by the pituitary is important for the maintenance of luteal functions (6). During midpregnancy, placental lactogens become critical for continued luteal function (7-9). In infraprimate species, including the rat, these lactogenie hormones regulate the synthesis of progesterone and peptide hormones by the corpus luteum (4-5). If implantation and placentation have not occurred, placental lactogens will be absent, resulting in luteolysis or regression of the corpus luteum. The mechanisms by which PRL or placental lactogens are able to direct the sustenance of the corpus luteum have not been clearly defined.
The Stat family of proteins (signal transducers and activators of transcription) have been characterized as latent cytoplasmic transcription factors that become activated through phosphorylation of tyrosine residues and are translocated to the nucleus in response to a variety of extracellular signaling proteins (cytokines, growth factors, and hormones) (10,ll).
In mammary glands, PRL stimulates the synthesis of casein by activating a DNA-binding activity specific for a response element upstream of the p-casein promoter (the PRL-inducible element (PIE)) (12). This DNA-binding activity was purified from sheep mammary glands and identified as a 92-kDa tyrosine-phosphorylated protein that was named mammary gland factor (13). The complementary DNA encoding this protein was sequenced and found to contain sequence homologies with known members of the Stat family of transcription factors and was, therefore, renamed Stat 5 (14) .
In Electrophoresis was carried out at 150 V for 2 h at room temperature.
The gel was dried and exposed to film. detected as described above. The blot was stripped and reprobed with a 1:lOOO dilution of the monoclonal antibody to Stat 3 for 1 h, followed by secondary antibody incubation and ECL detection, as described above.
Results
Detection of PIE-binding complexes in nuclear extracts from the ovaries of PRL-treated rats
The ovaries of rats primed with PMSG or day 5 pseudopregnant rats contain synchronous populations of granulosa and luteal cells, respectively.
Treatments of both of these cell types with PRL has been shown to enhance progesterone production (23). In the mammary gland, PRL has been shown to induce a DNA-binding activity specific for the PIE (13). To determine whether PIE-binding activity could be induced by PRL in the ovary, rats primed with PMSG or day 5 pseudopregnant rats were treated with PRL or PBS for 15,30, or 60 min. Nuclear extracts from the ovaries of PBS-and PRLtreated rats were analyzed for the ability to form specific PIE-binding complexes in a gel shift assay. Nuclear extracts from the ovaries of PMSG-primed rats, whether treated or not treated with PRL, contained no detectable PIE-binding activity (data not shown).
However, the administration of PRL to day 5 pseudopregnant rats resulted in the appearance of one PIE-binding protein complex in nuclear extracts (labeled A in Fig. l ), whereas nuclear extracts from the ovaries of PBS-injected pseudopregnant animals had no detectable PIE-binding activity. This PIE-binding activity was maximal 30 min after the injection of PRL (Fig. 1 ). From this experiment we conclude that PRL induces a DNA-binding activity specific for PIE in the ovaries of day 5 pseudopregnant rats. PRL (13, 14) . In liver, both Stat 1 and Stat 5 are tyrosine phosphorylated and capable of complexing with PIE in response to epidermal growth factor (16). We, therefore, analyzed nuclear extracts prepared from the ovaries of control and PRL-treated pseudopregnant rats for the presence of phosphotyrosine-containing proteins. Two major tyrosine-phosphorylated bands (92 and 90 kDa) could be seen after PRL injection (Fig. 2, leff palzel) . The concentrations of these nuclear proteins were highest at 30 min. Other minor tyrosine-phosphorylated proteins (120 and 50-55 kDa) were occasionally detected in nuclear extracts; however, changes in the intensities of these bands did not consistently correlate with PRL treatment.
Affinity purification and identification of PIE-binding proteins
No consistent change in protein phosphotyrosine content could be detected in nuclear extracts after PBS injection (Fig. 2, left panel) .
To determine whether the PRL-inducible 90-to 92-kDa tyrosine-phosphorylated proteins seen in the day 5 pseudopregnant rat ovarian nuclear extracts were related to Stat 5, the antiphosphotyrosine immunoblot was reprobed with a monoclonal anti-Stat 5 antibody. This procedure revealed the presence of Stat 5 in the nuclear extracts from PRL-injected animals, but not in nuclear extracts from PBS-injected animals (Fig. 2, vight panel) To confirm that the Stat 5 protein was tyrosine phosphorylated after the injection of PRL, total cell extracts from the ovaries of PBS-and PRL-injected animals were immunoprecipitated with the antibody specific for Stat 5. The precipitated proteins were resolved by SDS-PAGE and then analyzed by immunoblotting with an antibody to phosphotyrosine and an antibody to Stat 5. The anti-Stat 5 immunoprecipitate contained a tyrosine-phosphorylated protein of approximately 92 kDa only when prepared from the ovaries of PRLtreated animals and not from those of control animals (Fig.   3, left panel) . Probing the blot with the monoclonal antibody to Stat 5 revealed that Stat 5 was present in immunoprecipitates prepared from ovaries of both control and PRL-treated animals (Fig. 3, right panel) To directly determine whether the PRL-induced PIE-binding complexes present in nuclear extracts contained Stat 5, we performed supershift analyses with an antibody specific for this protein (Fig. 4b) . Little PIE-specific binding was detectable in nuclear extracts from the ovaries of PBS-treated day 5 pseudopregnant rats. Nuclear extracts from the ovaries of PRL-treated day 5 pseudopregnant rats contained one specific PIE-binding complex (labeled A in Fig. 4b ). Fig. 5 , with two animals in each group. As a control, the blot was reprobed with a monoclonal antibody specific for Stat 3. This control indicates that there is no apparent change in the relative protein concentration of Stat 3 after hCG administration.
From this experiment we conclude that the expression of Stat 5 protein is induced after luteinization of the ovarian follicle.
Discussion
We demonstrated that the tyrosine phosphorylation of Stat 5 and its translocation to the nucleus is an event initiated in the ovaries of day 5 pseudopregnant rats after the administration of PRL. The genes that are regulated in the ovary in response to the activation of Stat 5 protein by PRL are not currently known. Even though Stat 5 DNA-binding activity was detected using a response element upstream of the p-casein promoter, we do not believe that p-casein gene expression is being activated in these ovaries. In view of the ability of PRL to maintain the corpus luteum, it is possible that PRL could act to inhibit the expression of genes involved in luteal regression and apoptosis. the steroidogenic pathway, including I'450 side-chain cleavage enzyme (CYPllA), and 3P-hydroxysteroid dehydrogenase as well as genes metabolizing steroids such as 20~ hydroxysteroid dehydrogenase (24). The promoter of the gonadal isoform of human 3P-hydroxysteroid dehydrogenase (type II) contains a 9/9 match with the PIE (mammary gland factor) consensus recognition element at -118 to -110. The rat promoter of this gene has not yet been cloned or characterized. It is currently not known whether this element is functional, although previous data indicated that the expression of this gene in rat ovaries is regulated by PRL (17, 18). The human I'450 side-chain cleavage enzyme promoter also contains two 9 / 9 putative Stat 5 recognition elements at -514 to -506 and at -2125 to -2116. The function of these putative recognition elements in PRL-induced transcriptional regulation of these genes is currently unknown.
The pseudopregnant model is ideal for determining the cellular signals occurring in the ovary in response to PRL. During the initial phase of pseudopregnancy, PRL is secreted by the pituitary and functions to promote maintenance of the corpus luteum (6). Pseudopregnant animals undergo two daily surges of PRL secretion, one in the early morning and one in the late afternoon (19, 20) . At times between these two surges, endogenous PRL concentrations are decreased by lo-fold. Our experiments were carried out between the diurnal PRL surges, and we were able to detect the effect of exogenous PRL.
Trophoblast tissue from uterine implantation of an embryo releases placental lactogens that bind to ovarian PRL receptors and promote maintenance of the corpus luteum. The injection of PRL should, therefore, mimic an implantation event. In view of our results, we conclude that the activation of Stat 5 may be one of the events initiated in the ovary after implantation of an embryo.
Luteal cells that develop in the ovaries of day 5 pseudopregnant rats have relatively more Stat 5 protein than the granulosa precursor cells. If Stat 5 is altering the transcription of the same genes in both cell types, then the increased amount of Stat 5 in corpora luteal cells may function to increase their transcriptional rates. Precedence for this idea comes from the observation that multiple response elements in tandem result in more transcription factor binding, thus increasing the chances that polymerase is recruited to the intended promoter. As maintenance of the corpus luteum is dependent on detecting and responding to a placental lactogen, the increase in Stat 5 transcription factor might ensure detection of the PRL signal. If this hypothesis is true, then an animal deficient in Stat 5 might be incapable of maintaining pregnancy. 
